CN115844015A - Lycopene oil, lycopene preparation and application thereof - Google Patents
Lycopene oil, lycopene preparation and application thereof Download PDFInfo
- Publication number
- CN115844015A CN115844015A CN202211553069.8A CN202211553069A CN115844015A CN 115844015 A CN115844015 A CN 115844015A CN 202211553069 A CN202211553069 A CN 202211553069A CN 115844015 A CN115844015 A CN 115844015A
- Authority
- CN
- China
- Prior art keywords
- lycopene
- preparation
- oil
- oleogel
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 title claims abstract description 141
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 title claims abstract description 120
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 title claims abstract description 120
- 235000012661 lycopene Nutrition 0.000 title claims abstract description 120
- 239000001751 lycopene Substances 0.000 title claims abstract description 120
- 229960004999 lycopene Drugs 0.000 title claims abstract description 120
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 title claims abstract description 120
- 238000002360 preparation method Methods 0.000 claims abstract description 33
- 239000002245 particle Substances 0.000 claims abstract description 11
- 239000007788 liquid Substances 0.000 claims description 28
- 239000000839 emulsion Substances 0.000 claims description 21
- 239000011261 inert gas Substances 0.000 claims description 15
- 239000003921 oil Substances 0.000 claims description 14
- 235000019198 oils Nutrition 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- -1 fatty acid esters Chemical class 0.000 claims description 9
- 239000013078 crystal Substances 0.000 claims description 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
- 239000000194 fatty acid Substances 0.000 claims description 8
- 229930195729 fatty acid Natural products 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 7
- 239000004519 grease Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000004530 micro-emulsion Substances 0.000 claims description 6
- 239000000828 canola oil Substances 0.000 claims description 5
- 235000019519 canola oil Nutrition 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 238000004945 emulsification Methods 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 239000002285 corn oil Substances 0.000 claims description 3
- 235000005687 corn oil Nutrition 0.000 claims description 3
- 238000010008 shearing Methods 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 108010076119 Caseins Chemical class 0.000 claims description 2
- 102000011632 Caseins Human genes 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 229920000223 polyglycerol Polymers 0.000 claims description 2
- 229940080237 sodium caseinate Drugs 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 2
- 150000003904 phospholipids Chemical class 0.000 claims 2
- 229920000881 Modified starch Polymers 0.000 claims 1
- 239000004368 Modified starch Substances 0.000 claims 1
- 108010073771 Soybean Proteins Chemical class 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 238000005243 fluidization Methods 0.000 claims 1
- 235000019426 modified starch Nutrition 0.000 claims 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims 1
- 235000019960 monoglycerides of fatty acid Nutrition 0.000 claims 1
- 239000004006 olive oil Substances 0.000 claims 1
- 235000008390 olive oil Nutrition 0.000 claims 1
- 239000008159 sesame oil Substances 0.000 claims 1
- 235000011803 sesame oil Nutrition 0.000 claims 1
- 235000019710 soybean protein Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 235000020238 sunflower seed Nutrition 0.000 claims 1
- 239000000463 material Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000007908 nanoemulsion Substances 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000005913 Maltodextrin Substances 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- 239000011162 core material Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Natural products CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Images
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
技术领域technical field
本发明涉及食品、保健品、药品原料及产品,具体的涉及一种番茄红素油凝胶、番茄红素制剂及其应用。The invention relates to food, health products, pharmaceutical raw materials and products, in particular to a lycopene oil gel, a lycopene preparation and applications thereof.
背景技术Background technique
番茄红素是一种功能性的天然脂溶性色素,具有抗氧化、抗炎等一些生理功效。联合国粮食及农业组织、食品添加剂委员会和世界卫生组织已将番茄红色确定为A类营养素,并已广泛应用于保健食品、医药、化妆品、农业等领域。番茄红素是典型的异戊二烯类化合物,由于其不饱和键的存在很容易受到外部不良条件的影响而发生降解造成损失,因此市面上番茄红素为主要的保健品产品常以软胶囊和片剂等方式为主要的存在方式。Lycopene is a functional natural fat-soluble pigment, which has some physiological effects such as anti-oxidation and anti-inflammation. The Food and Agriculture Organization of the United Nations, the Committee on Food Additives and the World Health Organization have identified tomato red as a type A nutrient, and it has been widely used in health food, medicine, cosmetics, agriculture and other fields. Lycopene is a typical isoprene compound. Due to the existence of its unsaturated bonds, it is easily degraded and lost due to the influence of external adverse conditions. Therefore, lycopene is the main health care product on the market and often comes in soft capsules And tablet etc. are the main ways of existence.
由于番茄红素不溶于水,微溶于可食用油,在多种有机溶剂中溶解度也处于较低水平。没有有效食品级溶剂给番茄红素的富集增加了难度,从而影响了高载量剂型的开发。Since lycopene is insoluble in water, slightly soluble in edible oil, the solubility in various organic solvents is also at a low level. The lack of effective food-grade solvents increases the difficulty of enriching lycopene, thus affecting the development of high-load dosage forms.
乳液是一种以液滴形式均匀分散在另一种与之不相溶的液体中形成的运载体系。长期以来,食品乳液用于营养物质的递送中,可提高其稳定性,控制消化过程中的释放,最终提高对生物体的生物利用率,对开发具有理想健康益处和感官特性的功能性食品提供一种简单的方法。CN201510759680.X公开了一种包埋天然脂溶性色素的植物蛋白/大豆多糖纳米乳液,将番茄红素溶于油脂后,加入到植物酸溶蛋白和大豆多糖的混合溶液中,通过高压微射流纳米均质机在300~800bar压力下均质1~3min、将均质后的乳液在80~90℃加热0.5~1h,得到包埋番茄红素的植物蛋白/大豆多糖纳米乳液。但是该方法包埋的番茄红素的量有限,仅达到0.04~0.08g/100ml。CN201811637738 .3公开了使用麦芽糊精、浓缩乳清蛋白作为壁材,采用菜籽油作为油溶性营养元素的载体,与大豆卵磷脂、山梨糖醇等物质一起通过高压均质机均值,再利用高压微射流设备制备纳米脂质体液体,进而利用真空喷雾干燥技术干燥,得到微囊化纳米制剂。CN202210090802.0公开了利用阿拉伯胶、麦芽糊精、海藻酸钠为壁材,通过超临界流体萃取得到芯材番茄红素,再将芯材与壁材按比例 混合后超高压微射流,均质和乳化同步实现,制备番茄红素细乳液,经喷雾干燥得到番茄红素微胶囊。但是这些方法都存在产品的番茄红素载量较低的问题。Emulsion is a carrier system that is uniformly dispersed in the form of droplets in another immiscible liquid. For a long time, food emulsions have been used in the delivery of nutrients to enhance their stability, control their release during digestion, and ultimately increase their bioavailability to living organisms, providing support for the development of functional foods with desirable health benefits and sensory properties. An easy way. CN201510759680.X discloses a plant protein/soybean polysaccharide nanoemulsion embedding natural fat-soluble pigments. After lycopene is dissolved in oil, it is added to the mixed solution of plant acid-soluble protein and soybean polysaccharide, and the nano-emulsion is processed by high-pressure micro-jet nanoemulsion. The homogenizer is used for homogenizing under the pressure of 300-800 bar for 1-3 minutes, and the homogenized emulsion is heated at 80-90° C. for 0.5-1 hour to obtain a plant protein/soybean polysaccharide nanoemulsion embedding lycopene. However, the amount of lycopene embedded in this method is limited, only reaching 0.04-0.08g/100ml. CN201811637738.3 discloses the use of maltodextrin and concentrated whey protein as wall materials, rapeseed oil as the carrier of oil-soluble nutrients, and materials such as soybean lecithin and sorbitol, which are averaged by a high-pressure homogenizer, and reused Nano-liposome liquid is prepared by high-pressure micro-fluidic equipment, and then dried by vacuum spray drying technology to obtain microencapsulated nano-preparation. CN202210090802.0 discloses using gum arabic, maltodextrin, and sodium alginate as wall materials to obtain the core material lycopene through supercritical fluid extraction, and then mixing the core material and wall materials in proportion to ultra-high pressure micro-jet flow, homogeneous Simultaneous realization of emulsification, preparation of lycopene microemulsion, and spray drying to obtain lycopene microcapsules. However, these methods all have the problem that the lycopene load of the product is low.
发明内容Contents of the invention
本发明的目的在于克服现有产品的不足,旨在提供一种高浓度番茄红素油凝胶、高载量番茄红素制剂的制备方法及其应用。The purpose of the present invention is to overcome the deficiencies of the existing products, aiming to provide a high-concentration lycopene oleogel, a preparation method of a high-load lycopene preparation and its application.
本发明的首要目的是提供一种高浓度的番茄红素油凝胶,所述番茄红素油凝胶是在惰性气体保护下,利用高温热压仪将番茄红素晶体形成熔融番茄红素,再将熔融番茄红素与油脂混合均匀制备而成。The primary purpose of the present invention is to provide a high-concentration lycopene oleogel. The lycopene oleogel is under the protection of an inert gas, and the lycopene crystals are formed into molten lycopene by using a high-temperature autoclave. It is prepared by mixing molten lycopene and oil evenly.
本发明的一个方面,本发明提供了一种番茄红素油凝胶产品及制备方法,所述方法包括在惰性气体保护下,将番茄红素晶体放置在真空热压仪中,保持压力0.08~–0.1Mpa,保持时间10~20 min获得熔融番茄红素,加入油脂匀速搅拌均匀后并迅速冷却获得番茄红素油凝胶,所述番茄红素油凝胶中含40%的番茄红素。In one aspect of the present invention, the present invention provides a lycopene oleogel product and a preparation method, the method comprising placing lycopene crystals in a vacuum autoclave under the protection of an inert gas, and maintaining a pressure of 0.08 to - 0.1Mpa, hold for 10-20 minutes to obtain molten lycopene, add oil and stir evenly at a uniform speed, and cool rapidly to obtain lycopene oil gel, which contains 40% lycopene.
本发明的一个方面,本发明提供了一种番茄红素制剂,所述制剂中的番茄红素的粒径范围在200~400 nm,番茄红素含量的含量为10~20 mg/mL。In one aspect of the present invention, the present invention provides a lycopene preparation, the particle size range of lycopene in the preparation is 200-400 nm, and the content of lycopene is 10-20 mg/mL.
本发明的一个方面,本发明提供了一种番茄红素制剂的制备方法,所述方法包括如下步骤:One aspect of the present invention, the present invention provides a kind of preparation method of lycopene preparation, described method comprises the steps:
(1)将质量百分数为2%~8%的水溶性乳化剂预热到90~95℃获得A液;(1) Preheat the water-soluble emulsifier with a mass percentage of 2%~8% to 90~95°C to obtain liquid A;
(1)(2)将番茄红素油凝胶和油脂放入固定容器中,通入惰性气体进行保护,升高容器温度至 175~185℃,迅速搅拌,保持时间30~60 s,最后获得B液;优选的,所述油脂与制备番茄红素油凝胶所用的油脂为同一种油脂;(1) (2) Put the lycopene oleogel and oil into a fixed container, pass in an inert gas for protection, raise the temperature of the container to 175-185°C, stir rapidly, and keep it for 30-60 s, and finally obtain B Liquid; Preferably, the grease and the grease used for preparing lycopene oleogel are the same grease;
(3)将B液迅速加入到A液中,经高速剪切乳化,获得番茄红素粗乳液;(3) Quickly add liquid B to liquid A, emulsify through high-speed shearing, and obtain lycopene coarse emulsion;
(4)将步骤(3)获得的粗乳液经高压均质机获得番茄红素细乳液;(4) Pass the coarse emulsion obtained in step (3) through a high-pressure homogenizer to obtain a lycopene fine emulsion;
(5)将步骤(4)中获得的番茄红素细乳液灭菌后放置4℃冰箱保存,得到番茄红素制剂。(5) Sterilize the lycopene microemulsion obtained in step (4) and store it in a refrigerator at 4°C to obtain a lycopene preparation.
作为优选,本发明番茄红素制剂制备方法中所述步骤(3)中的高速剪切乳化为10000~12000 r/min,3~5 min。Preferably, the high-speed shear emulsification in step (3) in the preparation method of the lycopene preparation of the present invention is 10000-12000 r/min, 3-5 min.
作为优选,本发明番茄红素制剂制备方法中所述步骤(4)中的高压均质机为70~90 MPa,3次循环。Preferably, the high-pressure homogenizer in the step (4) of the preparation method of the lycopene preparation of the present invention is 70-90 MPa, 3 cycles.
作为优选,本发明番茄红素制剂制备方法中油相与水相的质量比为5:100~20:100;番茄红素与水相的质量比为1:100~4:100;乳化剂与水的质量比为2:100~8:100。Preferably, the mass ratio of the oil phase to the water phase in the preparation method of the lycopene preparation of the present invention is 5:100 to 20:100; the mass ratio of the lycopene to the water phase is 1:100 to 4:100; the emulsifier and water The mass ratio is 2:100~8:100.
本发明的一个方面,本发明的番茄红素油凝胶、番茄红素制剂可以用于制备食品、药品、保健品中的应用。该番茄红素制剂可以制备为液体口服液制剂,也可以在制剂的基础进一步的加工,例如喷雾干燥制备为微胶囊粉剂。当然,相应的含有本发明番茄红素油凝胶、番茄红素制剂的食品、药品、保健品还可以包括食品、药品中允许添加或使用的辅料或组分。In one aspect of the present invention, the lycopene oleogel and the lycopene preparation of the present invention can be used in the preparation of food, medicine and health products. The lycopene preparation can be prepared as a liquid oral liquid preparation, and can also be further processed on the basis of the preparation, such as spray-dried to prepare a microcapsule powder. Of course, the corresponding foods, medicines, and health products containing lycopene oleogel and lycopene preparations of the present invention may also include auxiliary materials or components that are allowed to be added or used in foods and medicines.
有益效果Beneficial effect
本发明通过在惰性气体保护下,采用真空热压仪制备获得高浓度番茄红素油凝胶,再进一步通过与乳化剂复合制备获得的稳定的番茄红素口服制剂产品。其中番茄红素油凝胶中含40%浓度的番茄红素、番茄红素口服制剂产品粒径范围在200~400 nm,番茄红素的含量达到10~40 mg/mL。本发明产品具有溶液粒径小、生物利用度高、产品性质稳定等特点。In the present invention, under the protection of an inert gas, a high-concentration lycopene oleogel is prepared by using a vacuum autoclave, and then compounded with an emulsifier to prepare a stable lycopene oral preparation product. Among them, lycopene oleogel contains 40% lycopene, and the particle size range of lycopene oral preparations is 200-400 nm, and the lycopene content reaches 10-40 mg/mL. The product of the invention has the characteristics of small solution particle size, high bioavailability, stable product properties and the like.
附图说明Description of drawings
图1:本发明番茄红素油凝胶产品。Fig. 1: The lycopene oleogel product of the present invention.
图2:本发明番茄红素制剂的粒径分布。Figure 2: Particle size distribution of lycopene formulations according to the invention.
图3:本发明番茄红素制剂产品。Fig. 3: Lycopene preparation product of the present invention.
具体实施方式Detailed ways
为了更好的理解本发明,下面结合具体实施方式对本发明做进一步的说明,但实施例并不对本发明做任何形式的限定。除非另有说明,本发明实施例采用的原料为常规购买的商用原料。In order to better understand the present invention, the present invention will be further described below in conjunction with specific embodiments, but the examples do not limit the present invention in any form. Unless otherwise specified, the raw materials used in the examples of the present invention are conventionally purchased commercial raw materials.
实施例1Example 1
1.1 番茄红素油凝胶的制备1.1 Preparation of lycopene oleogel
在惰性气体保护下,将番茄红素晶体放置在真空热压仪中,保持压力0.08~–0.1Mpa,保持时间20 min获得熔融番茄红素,加入芥花籽油匀速搅拌均匀后并迅速冷却获得番茄红素油凝胶,所述番茄红素油凝胶中含40%的番茄红素。Under the protection of an inert gas, place lycopene crystals in a vacuum autoclave, keep the pressure at 0.08-0.1Mpa, and keep for 20 minutes to obtain molten lycopene, add canola oil and stir evenly at a uniform speed, and cool quickly to obtain The lycopene oleogel contains 40% lycopene.
1.2 番茄红素口服制剂的制备1.2 Preparation of oral preparations of lycopene
(1)将质量百分数为2%的乳化剂蔗糖酯肪酸钠水溶液95 mL预热到90~95℃获得A液(1) Preheat 95 mL of an emulsifier sodium sucrose fatty acid aqueous solution with a mass percentage of 2% to 90-95°C to obtain liquid A
(2)将2.5 g番茄红素油凝胶和2.5 g芥花籽油混合加入固定容器中,在惰性气体的保护下将温度升高至175~185℃保持15 s,获得B液。(2) Mix 2.5 g lycopene oleogel and 2.5 g canola oil into a fixed container, raise the temperature to 175-185°C for 15 s under the protection of inert gas, and obtain liquid B.
(3)将B液迅速加入到A液中,经高速剪切乳化(10000 r/min,3 min),获得番茄红素粗乳液。(3) Liquid B was quickly added to liquid A, and emulsified by high-speed shear (10000 r/min, 3 min) to obtain lycopene coarse emulsion.
(4)将步骤(3)获得的粗乳液经高压均质机(70MPa,3次循环)获得番茄红素细乳液。(4) Pass the coarse emulsion obtained in step (3) through a high-pressure homogenizer (70MPa, 3 cycles) to obtain a lycopene fine emulsion.
(5)将步骤(4)中获得的番茄红素细乳液迅速冷却,获得番茄红素口服制剂。其中番茄红素含量为10 mg/mL,番茄红素细乳液的平均粒径为226 nm。(5) Rapidly cooling the lycopene miniemulsion obtained in step (4) to obtain an oral preparation of lycopene. The content of lycopene is 10 mg/mL, and the average particle size of lycopene miniemulsion is 226 nm.
实施例2Example 2
2.1 番茄红素油凝胶的制备2.1 Preparation of lycopene oleogel
在惰性气体保护下,将番茄红素晶体放置在真空热压仪中,保持压力0.08~–0.1Mpa,保持时间20 min获得熔融番茄红素,加入大豆油油匀速搅拌均匀后并迅速冷却获得番茄红素油凝胶,所述番茄红素油凝胶中含40%的番茄红素。Under the protection of an inert gas, place lycopene crystals in a vacuum autoclave, keep the pressure at 0.08-0.1Mpa, and keep for 20 minutes to obtain molten lycopene, add soybean oil and stir evenly at a uniform speed, and quickly cool to obtain tomato Lycopene oleogel, containing 40% lycopene in the lycopene oleogel.
2.2 番茄红素口服制剂的制备2.2 Preparation of oral preparations of lycopene
(1)将质量百分数为4%的酪蛋白酸钠水溶液90 mL预热到90~95℃获得A液(1) Preheat 90 mL of 4% sodium caseinate aqueous solution to 90-95°C to obtain liquid A
(2)将5 g番茄红素油凝胶和5 g大豆油混合加入固定容器中,在惰性气体的保护下将温度升高至175~185℃保持30 s,获得B液。(2) Mix 5 g of lycopene oleogel and 5 g of soybean oil into a fixed container, raise the temperature to 175-185°C for 30 s under the protection of an inert gas, and obtain liquid B.
(3)将B液迅速加入到A液中,经高速剪切乳化(10000 r/min,3.5 min),获得番茄红素粗乳液。(3) Liquid B was quickly added to liquid A, and subjected to high-speed shear emulsification (10000 r/min, 3.5 min) to obtain a lycopene coarse emulsion.
(4)将步骤(3)获得的粗乳液经高压均质机(70MPa,3次循环)获得番茄红素细乳液。(4) Pass the coarse emulsion obtained in step (3) through a high-pressure homogenizer (70MPa, 3 cycles) to obtain a lycopene fine emulsion.
(5)将步骤(4)中获得的番茄红素细乳液灭菌后放置4℃保存,获得番茄红素口服制剂。其中番茄红素含量为20 mg/mL,番茄红素细乳液的平均粒径为262 nm。(5) The lycopene microemulsion obtained in step (4) is sterilized and stored at 4°C to obtain an oral lycopene preparation. The content of lycopene is 20 mg/mL, and the average particle size of lycopene miniemulsion is 262 nm.
实施例3Example 3
3.1 番茄红素油凝胶的制备3.1 Preparation of lycopene oleogel
在惰性气体保护下,将番茄红素晶体放置在真空热压仪中,保持压力0.08~–0.1Mpa,保持时间20 min获得熔融番茄红素,加入玉米油匀速搅拌均匀后并迅速冷却获得番茄红素油凝胶,所述番茄红素油凝胶中含40%的番茄红素。Under the protection of an inert gas, place lycopene crystals in a vacuum autoclave, keep the pressure at 0.08-0.1Mpa, and keep for 20 minutes to obtain molten lycopene, add corn oil and stir evenly at a uniform speed, and quickly cool to obtain lycopene Vegetarian oil gel, containing 40% lycopene in the said lycopene oil gel.
3.2 番茄红素口服制剂的制备3.2 Preparation of oral preparations of lycopene
(1)将质量百分数为6%的聚甘油脂肪酸酯水溶液85 mL预热到90~95℃获得A液(1) Preheat 85 mL of 6% polyglycerol fatty acid ester aqueous solution to 90-95°C to obtain liquid A
(2)将7.5 g番茄红素油凝胶和7.5 g玉米油混合加入固定容器中,在惰性气体的保护下将温度升高至175~185℃保持45 s,获得B液。(2) Mix 7.5 g lycopene oleogel and 7.5 g corn oil into a fixed container, raise the temperature to 175-185°C for 45 s under the protection of inert gas, and obtain liquid B.
(3)将B液迅速加入到A液中,经高速剪切乳化(120000 r/min,4 min),获得番茄红素粗乳液。(3) Liquid B was quickly added to liquid A, and emulsified by high-speed shearing (120000 r/min, 4 min) to obtain lycopene coarse emulsion.
(4)将步骤(3)获得的粗乳液经高压均质机(80MPa,3次循环)获得番茄红素细乳液。(4) Pass the coarse emulsion obtained in step (3) through a high-pressure homogenizer (80MPa, 3 cycles) to obtain a lycopene fine emulsion.
(5)将步骤(4)中获得的番茄红素细乳液灭菌后放置4℃冰箱中保存,获得番茄红素口服制剂。其中番茄红素含量为30 mg/mL,番茄红素细乳液的平均粒径为312 nm。(5) Sterilize the lycopene microemulsion obtained in step (4) and store it in a refrigerator at 4°C to obtain an oral lycopene preparation. The content of lycopene is 30 mg/mL, and the average particle size of lycopene miniemulsion is 312 nm.
实施例4Example 4
3.1 番茄红素油凝胶的制备3.1 Preparation of lycopene oleogel
在惰性气体保护下,将番茄红素晶体放置在真空热压仪中,保持压力0.08~–0.1Mpa,保持时间20 min获得熔融番茄红素,加入芥花籽油匀速搅拌均匀后并迅速冷却获得番茄红素油凝胶,所述番茄红素油凝胶中含40%的番茄红素。Under the protection of an inert gas, place lycopene crystals in a vacuum autoclave, keep the pressure at 0.08-0.1Mpa, and keep for 20 minutes to obtain molten lycopene, add canola oil and stir evenly at a uniform speed, and cool quickly to obtain The lycopene oleogel contains 40% lycopene.
3.2 番茄红素口服制剂的制备3.2 Preparation of oral preparations of lycopene
(1)将质量百分数为8%的蔗糖酯肪酸钠水溶液80 mL预热到90~95℃获得A液(1) Preheat 80 mL of 8% sucrose fatty acid sodium aqueous solution to 90-95°C to obtain liquid A
(2)将10 g番茄红素油凝胶和10 g芥花籽油混合加入固定容器中,在惰性气体的保护下将温度升高至175~185℃保持60 s,获得B液。(2) Mix 10 g lycopene oleogel and 10 g canola oil into a fixed container, raise the temperature to 175-185°C for 60 s under the protection of inert gas, and obtain liquid B.
(3)将B液迅速加入到A液中,经高速剪切乳化(12000 r/min,5 min),获得番茄红素粗乳液。(3) Liquid B was quickly added to liquid A, and emulsified by high-speed shear (12000 r/min, 5 min) to obtain a lycopene coarse emulsion.
(4)将步骤(3)获得的粗乳液经高压均质机(90MPa,3次循环)获得番茄红素细乳液。(4) Pass the coarse emulsion obtained in step (3) through a high-pressure homogenizer (90MPa, 3 cycles) to obtain a lycopene fine emulsion.
(5)将步骤(4)中获得的番茄红素细乳液灭菌后放置4℃冰箱中保存,获得番茄红素口服制剂。其中番茄红素含量为40 mg/mL,番茄红素细乳液的平均粒径为345 nm。(5) Sterilize the lycopene microemulsion obtained in step (4) and store it in a refrigerator at 4°C to obtain an oral lycopene preparation. The content of lycopene is 40 mg/mL, and the average particle size of lycopene miniemulsion is 345 nm.
以上内容是结合具体实施方式对本发明作进一步详细说明,不能认定本发明具体实施只局限于这些说明,对于本发明所属技术领域的普通技术人员来说,在不脱离本发明的构思的前提下,还可以做出若干简单的推演或替换,都应当视为属于本发明所提交的权利要求书确定的保护范围。The above content is a further detailed description of the present invention in conjunction with specific embodiments. It cannot be determined that the specific implementation of the present invention is limited to these descriptions. For those of ordinary skill in the technical field of the present invention, without departing from the concept of the present invention. Several simple inferences or substitutions can also be made, all of which should be deemed to belong to the protection scope determined by the claims submitted in the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211553069.8A CN115844015A (en) | 2022-12-06 | 2022-12-06 | Lycopene oil, lycopene preparation and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211553069.8A CN115844015A (en) | 2022-12-06 | 2022-12-06 | Lycopene oil, lycopene preparation and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115844015A true CN115844015A (en) | 2023-03-28 |
Family
ID=85670142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211553069.8A Pending CN115844015A (en) | 2022-12-06 | 2022-12-06 | Lycopene oil, lycopene preparation and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115844015A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1365626A (en) * | 2002-02-08 | 2002-08-28 | 陈焕忠 | Nano-chalss natural lycopene product and its preparing process |
CN101092521A (en) * | 2007-07-17 | 2007-12-26 | 江南大学 | Product of Nano disperseion of water-soluble lycopene |
CN106213515A (en) * | 2016-07-22 | 2016-12-14 | 江南大学 | A kind of high bioavailability lycopene oral liquid product and preparation method |
CN106509902A (en) * | 2016-12-01 | 2017-03-22 | 华南农业大学 | Lycopene-loaded nano-emulsion and preparation method thereof |
CN106539082A (en) * | 2016-10-17 | 2017-03-29 | 大兴安岭林格贝寒带生物科技股份有限公司 | Oil suspension preparation method rich in lycopene and anthocyanidin |
-
2022
- 2022-12-06 CN CN202211553069.8A patent/CN115844015A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1365626A (en) * | 2002-02-08 | 2002-08-28 | 陈焕忠 | Nano-chalss natural lycopene product and its preparing process |
CN101092521A (en) * | 2007-07-17 | 2007-12-26 | 江南大学 | Product of Nano disperseion of water-soluble lycopene |
CN106213515A (en) * | 2016-07-22 | 2016-12-14 | 江南大学 | A kind of high bioavailability lycopene oral liquid product and preparation method |
CN106539082A (en) * | 2016-10-17 | 2017-03-29 | 大兴安岭林格贝寒带生物科技股份有限公司 | Oil suspension preparation method rich in lycopene and anthocyanidin |
CN106509902A (en) * | 2016-12-01 | 2017-03-22 | 华南农业大学 | Lycopene-loaded nano-emulsion and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
师月: "番茄红素油脂凝胶的制备、表征与应用", 中国优秀硕士学位论文全文数据库, no. 09, pages 162 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Okuro et al. | Perspective on oleogelator mixtures, structure design and behaviour towards digestibility of oleogels | |
Donhowe et al. | Characterization and in vitro bioavailability of β-carotene: Effects of microencapsulation method and food matrix | |
Chang et al. | Encapsulation of omega 3-6-9 fatty acids-rich oils using protein-based emulsions with spray drying | |
Lohith Kumar et al. | Encapsulation of bioactive compounds using nanoemulsions | |
Aboalnaja et al. | Utilization of nanoemulsions to enhance bioactivity of pharmaceuticals, supplements, and nutraceuticals: Nanoemulsion delivery systems and nanoemulsion excipient systems | |
CN108430461B (en) | Preparation method of high-stability microcapsule dry powder/particles containing fat-soluble nutrients with more double bonds | |
Sari et al. | Preparation and characterization of nanoemulsion encapsulating curcumin | |
McClements et al. | Emulsion‐based delivery systems for lipophilic bioactive components | |
Celli et al. | Bioactive encapsulated powders for functional foods—a review of methods and current limitations | |
US10646450B2 (en) | Delivery system comprising a core and a digestible polymer shell | |
AU2008340061B2 (en) | Microcapsules comprising a fat -soluble active substance | |
CN105996040A (en) | Microcapsule powder and preparation method thereof | |
JP5490795B2 (en) | Improved emulsification system for nutritional compositions | |
KR101763947B1 (en) | Method of microcapsulating phosphatidylserine | |
CN108338360A (en) | A kind of high temperature resistant distinctive unsaturated fat acid lipid microcapsule powder and preparation method thereof | |
CN107836716B (en) | Algae oil microcapsule and preparation method and application thereof | |
CN101019838A (en) | Linseed oil microcapsule powder and its prepn | |
CN105942525A (en) | Olive oil microcapsule powder and preparation method thereof | |
CN104207143A (en) | Nanoscale docosahexaenoic acid emulsion and preparation method thereof | |
WO2008020680A1 (en) | The method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule | |
Yang et al. | Conjugated linoleic acid loaded starch-based emulsion nanoparticles: In vivo gastrointestinal controlled release | |
CN105995978A (en) | Perilla oil composition and perilla oil microcapsule powder and preparation method thereof | |
US20160143332A1 (en) | Stable oil suspensions with enhanced bioavailability and compositions thereof | |
Homroy et al. | Role of encapsulation on the bioavailability of omega‐3 fatty acids | |
Cai et al. | Encapsulated microstructures of beneficial functional lipids and their applications in foods and biomedicines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |